Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study
出版年份 2021 全文链接
标题
Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study
作者
关键词
-
出版物
PSYCHIATRY RESEARCH
Volume 303, Issue -, Pages 114058
出版商
Elsevier BV
发表日期
2021-06-07
DOI
10.1016/j.psychres.2021.114058
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study
- (2019) Fernanda S. Correia-Melo et al. JOURNAL OF AFFECTIVE DISORDERS
- Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine: Role of BDNF-TrkB signaling
- (2019) Yunfei Tan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The profile of cognitive impairments in chronic ketamine users
- (2018) Xiaoyin Ke et al. PSYCHIATRY RESEARCH
- Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion
- (2018) Mu-Hong Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder
- (2018) Wei Zheng et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Neuropsychological Clustering in Bipolar and Major Depressive Disorder
- (2017) Charles Cotrena et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- The interrelationship between attentional and executive deficits in major depressive disorder
- (2016) J. Nilsson et al. ACTA PSYCHIATRICA SCANDINAVICA
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
- (2016) Weili Zhu et al. Neuroscience Bulletin
- Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis
- (2015) Ellen E. Lee et al. GENERAL HOSPITAL PSYCHIATRY
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
- (2014) Paulo R. Shiroma et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
- (2014) James W Murrough et al. NEUROPSYCHOPHARMACOLOGY
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Long-Term Heavy Ketamine Use is Associated with Spatial Memory Impairment and Altered Hippocampal Activation
- (2014) Celia J. A. Morgan et al. Frontiers in Psychiatry
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
- (2013) James W. Murrough et al. PSYCHOPHARMACOLOGY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Cognitive impairment in euthymic major depressive disorder: a meta-analysis
- (2012) E. Bora et al. PSYCHOLOGICAL MEDICINE
- A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder
- (2011) Rico S.C. Lee et al. JOURNAL OF AFFECTIVE DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started